LOPERAMIDE HYDROCHL

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 11,000 packages of LOPERAMIDE HYDROCHLORIDE (NSN 6505015495732) at a unit price of $0.80, resulting in a total contract value of $8.80. The award was issued on July 14, 2026, with a single delivery scheduled for July 29, 2026, to arrive at Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor assumes all shipping costs and risks until delivery. Packaging and marking requirements mandate the inclusion of the manufacturer’s CAGE code, part number, and a traceable control number, with shipments restricted to traceable methods only—parcel post is prohibited. No specific preservation, environmental controls, or MIL-STD specifications are outlined. The contractor must submit invoices electronically via the Wide Area Workflow system in accordance with DFARS 252.232-7003, and payment will be processed by the Defense Finance and Accounting Service in Columbus, Ohio, referencing the appropriation code BX: 97X4930 5CBX 001 2620 S33189. Contract administration is managed by DLA Troop Support in Philadelphia, with Lisa Quinn serving as the Contracting/Ordering Officer and Shairy M. Cartagena as the local point of contact. The contract reflects a straightforward procurement of a standard pharmaceutical product, lacking detailed technical specifications, evaluation criteria, socioeconomic certifications, or special requirements. Inspection and acceptance occur at the destination by the government, ensuring conformance to contract terms without reference to external quality standards. The absence of clause listings, contract type designation, or award rationale suggests this is a minimal administrative action under an existing indefinite-delivery contract, likely awarded on a Lowest Price Technically Acceptable basis due to the simplicity and standardization of the item procured.